Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07122245 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Demographics of Lung Cancer in Females

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 10 months later Feb 7, 2026 → Dec 7, 2026
See other at-risk trials from Mansoura University Hospital

Record History

  1. Primary completion pushed from Feb 7, 2026 to Dec 7, 2026
    • Study completion pushed from Apr 7, 2026 to Apr 7, 2027
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Lung cancer has been the most common and fatal type of cancer; indeed worldwide incidence of lung cancer is alarming. It is considered a leading cause of cancer- related deaths among males and females due to environmental pollution, occupational exposure, genetic susceptibility, increasing number of smokers and others.
Trial Details
NCT Number NCT07122245
Lead Sponsor Mansoura University Hospital
Conditions
(from sponsor)		 Lung Cancer
Related terms Lung Neoplasms
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov